How prefrontal somatostatin brain cells influence reward-seeking
Mechanisms of operant reward seeking in prefrontal somatostatin-expressing interneurons
Looks at whether specific prefrontal brain cells that use GABA control reward-driven behavior, which could help people with addiction.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Alabama at Birmingham NIH-funded |
| Lab location | 1 site (Birmingham, United States) |
| Project ID | NIH-11319790 on NIH RePORTER |
What this research studies
This research focuses on special inhibitory brain cells called somatostatin-expressing interneurons in the medial prefrontal cortex and how they shape reward and motivation. The team uses rodent models, drug exposures (including opioid and alcohol-related paradigms), and advanced lab tools to record and manipulate these neurons during reward-seeking. By mapping how these cells change with drugs and natural rewards, they aim to reveal mechanisms that could guide future treatment targets. This is lab-based work at the University of Alabama at Birmingham and does not directly enroll people.
Who could benefit from this research
Good fit: People with substance use disorders (for example alcohol or opioid use) are the patient groups most likely to benefit from therapies that might arise from this work.
Not a fit: Patients without reward-related or addiction problems, or those seeking immediate clinical treatment, are unlikely to directly benefit from this basic science project.
Why it matters
Potential benefit: If successful, the work could identify new brain-cell targets to guide treatments that reduce compulsive drug use.
How similar studies have performed: Prior rodent studies, including from this group, have linked somatostatin interneurons to fear and drug responses, but translating these findings into human therapies has not yet been demonstrated.
Where this research is happening
Birmingham, United States
- University of Alabama at Birmingham — Birmingham, United States (Active)
Researchers
- Principal investigator: Cummings, Kirstie Alyssa — University of Alabama at Birmingham
- Study coordinator: Cummings, Kirstie Alyssa
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.